Wednesday, January 6, 2016

Valeant Names Interim CEO

Valeant Pharmaceuticals named Howard B. Schiller interim chief executive, effective immediately, while its CEO, Michael Pearson, remains on medical leave.

from WSJ.com: US Business http://ift.tt/1SzR40i
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)